The short answer
Have garlic supplements reviewed by your HIV care team before using them with atazanavir. Available original studies do not establish a uniform effect for this exact combination, and results with other antiviral regimens differ.
What this answer covers
Garlic preparations with oral atazanavir, distinguishing boosted regimens, concentrated supplements and food. Accessible original human studies used other protease inhibitors.
- Supplement or preparation
- Allium sativum
- Medication ingredient
- atazanavir
Check the exact medicine and regimen
This review concerns oral atazanavir, supplied as atazanavir sulfate in products such as REYATAZ. Capsule and powder instructions and the use of a booster must match the prescription. An unboosted study does not establish the same exposure change in every boosted combination.
One antiviral study cannot stand for all
A small study found reduced exposure to unboosted saquinavir with a particular garlic supplement. Saquinavir is a different medicine from atazanavir, and an unboosted regimen differs from atazanavir with ritonavir or cobicistat. The measured reduction should not be assigned to atazanavir or ordinary food garlic.
A different garlic study found no significant change
Four days of a defined garlic extract did not significantly change single-dose ritonavir exposure in ten volunteers. This short study does not prove safety during chronic boosted atazanavir treatment, but it shows why a universal effect cannot be assumed across products and regimens.
Review the actual preparation
Show the garlic brand, dose and ingredients, and describe unusually large dietary amounts to the care team. Do not replace HIV treatment with garlic or adjust atazanavir based on another drug’s study. No validated garlic-spacing interval was identified for this exact regimen; product review and appropriate viral monitoring are more useful.
Evidence and practical considerations
Absorption & effectiveness
The exact atazanavir-garlic magnitude and preparation scope cannot be established from the accessible original evidence; other-drug studies are not interchangeable.
- Exact scope
- Garlic preparations with oral atazanavir, distinguishing boosted regimens, concentrated supplements and food. Accessible original human studies used other protease inhibitors. with RxNorm 343047 IN atazanavir. REYATAZ sulfate capsules/powder with base-equivalent strengths; boosted and unboosted regimens explicitly differ. Other protease inhibitors not treated as equivalent.
- Medication form and route
- Oral
What remains uncertain
- Target atazanavir case PMID23925384 identified, but has no indexed abstract and original publisher403; secondary summaries were discovery only, not promoted to verified case details. Accessible saquinavir/ritonavir studies are indirect and differ in product/exposure.
Factors that may matter: Exact oral regimen and formulation; Booster or fixed-combination context; Mineral preparation and dosing order; Food requirements.
Read the supporting source summaries
Source 1: Current original prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed the specified oral regimen.
Administer atazanavir two hours before or one hour after antacids/buffered medicines. Hypericum contraindicated; gastric acidity and CYP3A susceptibility matter.
How this applies: RxNorm 343047 IN atazanavir. REYATAZ sulfate capsules/powder with base-equivalent strengths; boosted and unboosted regimens explicitly differ. Other protease inhibitors not treated as equivalent.
High-dose PPI research is not an antacid effect size. Garlic studies with other protease inhibitors and target inaccessible case remain distinguished.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Ten healthy volunteers.
Saquinavir exposure fell with the tested preparation.
How this applies: Exact reported regimen, preparation and endpoints only; other drugs or forms remain indirect.
Abstract-only other protease inhibitor and regimen, not atazanavir or ordinary food garlic.
Source 3: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Ten healthy volunteers in crossover.
No statistically significant change in ritonavir exposure.
How this applies: Exact reported regimen, preparation and endpoints only; other drugs or forms remain indirect.
Abstract-only; short exposure and single ritonavir dose are not chronic boosted atazanavir. PMC fullTextXML404; original indexed abstract read. No proof of target-pair safety.
Source 4: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
atazanavir is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Sources checked and article drafted. |
Article revision: 07bc14409c777ccd
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.